Information for
Healthcare Providers

The Benefits of Chlorhexidine

Chlorhexidine is a broad-spectrum disinfectant and antiseptic that significantly reduces the occurrence of CLABSI-causing pathogens.1
Download brochure Contact us

What is Chlorhexidine?

Understand the properties of chlorhexidine to support strategies to reduce central line-associated bloodstream infections (CLABSI).

Discover more

Protects against
microbial colonization1

Chlorhexidine kills organisms
and protects against microbial
colonization and, subsequently,
biofilm development.1

Broader spectrum
than antibiotics2

And has a faster kill rate
than other antimicrobials
(eg, povidone-iodine).2

Bacterial uptake typically
within 20 seconds2

Chlorhexidine kills by
distrupting the cell
membrane.3

Destroys main
categories of microbes2

Limited risk for the
development of an
opportunistic infection.2

When you think
Infection Prevention, think Arrowg+ard Blue Plus™ Technology

CLABSI Reduction

Arrowg+ard Blue Plus™ Catheters are proven to reduce central line‑associated bloodstream infection (CLABSI) by 67% to 100%.4-7

Evidence-Based

Proven effective against common antibiotic-resistant microorganisms and supported by 30+ clinical studies.8,9

See Arrowg+ard Blue Plus™ Protection in Action10,11

Please note that Vantex Oligon Catheter, featured in this video, may not be available in your country.
The comparison is for illustrative and educational purposes only, demonstrating how the product works.

Your Vascular
Access Partner

Your Vascular Access Partner

At Teleflex, we share your
commitment to patient safety.

We work with you to provide hands-on training and bedside coaching.

Chlorhexide Sensitivity Information

Webinar Resources

The Impact of Colonization and Infection on Vascular Devices The Impact of Colonization and Infection on Vascular Devices
The Clinical and Economic Impact of Central Venous Catheters The Clinical and Economic Impact of Central Venous Catheters
Vascular Access Infection Reduction Strategies from the ED to the ICU Webinar Vascular Access Infection Reduction Strategies from the ED to the ICU Webinar

Would you like to download our informational material?

Download brochure

Contact us

Teleflex is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. Please review the Teleflex Privacy Policy.

References:

  1. Mohammadi Z, Abbott PV. The properties and applications of chlorhexidine in endodontics. Int Endod J. 2009;42(4):288-302. doi:10.1111/j.1365-2591.2008.01540.x
  2. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147-179. doi:10.1128/CMR.12.1.147
  3. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27(2):97-96.
  4. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005;143(8):570-580. doi:10.7326/0003-4819-143-8-200510180-00007
  5. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. Am J Infect Control. 2014;42(3):321-324. doi:10.1016/j.ajic.2013.09.022
  6. Lorente L, Lecuona M, Jiménez A, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. Am J Infect Control. 2014;42(10):1130-1132. doi:10.1016/j.ajic.2014.06.027
  7. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. Am J Infect Control. 2016;44(12):1526-1529. doi:10.1016/j.ajic.2016.04.236
  8. Arrowg+ard Blue Protection Clinical References. MC-004390. Available from Teleflex.
  9. Arrowg+ard Blue Plus Protection Clinical References. MC-004391. Available from Teleflex.
  10. Mermel LA. What is the evidence for intraluminal colonization of hemodialysis catheters?. Kidney Int. 2014;86(1):28-33. doi:10.1038/ki.2013.527
  11. O’Grady NP, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections, 2011. CDC. Updated October 2017. Accessed January 29, 2024.
    https://www.cdc.gov/infectioncontrol/pdf/guidelines/bsi-guidelines-H.pdf

Contraindications:

The Arrowg+ard Blue™ and Arrowg+ard Blue Plus™ Catheters are contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue, Arrowg+ard Blue Advance, and Arrowg+ard Blue Plus are trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MCI-102066

OUR PRODUCTS
TELEFLEX MEDICAL OEM
SUPPLIERS
ABOUT US
CAREERS
INVESTORS
LEGAL
COMPLIANCE
PRIVACY
TRADEMARKS
GLOBAL REACH
SERVICES
CONTACT

© 2025 Teleflex Incorporated. All Rights Reserved.

Contacts